nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addendum to: Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency Using Post-Transplantation Cyclophosphamide
|
Shah, Nirali N. |
|
|
25 |
2 |
p. e65-e67 |
artikel |
2 |
Adults with Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission
|
Aldoss, Ibrahim |
|
|
25 |
2 |
p. e41-e45 |
artikel |
3 |
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
|
Marty, Francisco M. |
|
|
25 |
2 |
p. 369-381 |
artikel |
4 |
ASBMT Notes
|
|
|
|
25 |
2 |
p. 403-404 |
artikel |
5 |
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies
|
Choe, Hannah |
|
|
25 |
2 |
p. e60-e64 |
artikel |
6 |
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation
|
Norkin, Maxim |
|
|
25 |
2 |
p. 362-368 |
artikel |
7 |
Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese Patients
|
Ito, Reiko |
|
|
25 |
2 |
p. 293-300 |
artikel |
8 |
Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation
|
Hoodin, Flora |
|
|
25 |
2 |
p. 343-353 |
artikel |
9 |
Collection, Cryostorage, Transplantation, and Disposal of Hematopoietic Stem Cell Products
|
Kriegsmann, Katharina |
|
|
25 |
2 |
p. 382-390 |
artikel |
10 |
Comparable Outcomes of Allogeneic Peripheral Blood versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis
|
Ghavamzadeh, Ardeshir |
|
|
25 |
2 |
p. 307-312 |
artikel |
11 |
Editorial Board
|
|
|
|
25 |
2 |
p. A7 |
artikel |
12 |
Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation
|
Davis, Jessica M. |
|
|
25 |
2 |
p. 391-397 |
artikel |
13 |
High-Dose Chemotherapy with Early Autologous Stem Cell Transplantation Compared to Standard Dose Chemotherapy or Delayed Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
|
Jain, Tania |
|
|
25 |
2 |
p. 239-247 |
artikel |
14 |
Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial
|
Czerw, Tomasz |
|
|
25 |
2 |
p. 248-255 |
artikel |
15 |
In Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease
|
Delens, Loïc |
|
|
25 |
2 |
p. 204-215 |
artikel |
16 |
KIR Genotyping Data of More Than 3 Million Individuals Are Available for Global Unrelated Stem Cell Donor Searches (Comment to: Weisdorf D, Cooley S, Wang T, et al. KIR donor selection: feasibility in identifying better donors. Biol Blood Marrow Transplant. 2018; doi: 10.1016/j.bbmt.2018.08.022.)
|
Schmidt, Alexander H. |
|
|
25 |
2 |
p. e39-e40 |
artikel |
17 |
Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)
|
Wadhwa, Aman |
|
|
25 |
2 |
p. 328-334 |
artikel |
18 |
Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
|
Robin, Christine |
|
|
25 |
2 |
p. 354-361 |
artikel |
19 |
Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion
|
Künkele, Annette |
|
|
25 |
2 |
p. 223-232 |
artikel |
20 |
Masthead (Purpose and Scope)
|
|
|
|
25 |
2 |
p. A6 |
artikel |
21 |
Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications
|
Watts, Nicole L. |
|
|
25 |
2 |
p. 233-238 |
artikel |
22 |
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
|
Inamoto, Yoshihiro |
|
|
25 |
2 |
p. e46-e54 |
artikel |
23 |
Officers and Directors of ASBMT
|
|
|
|
25 |
2 |
p. A8 |
artikel |
24 |
Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia
|
Lund, Troy C. |
|
|
25 |
2 |
p. 301-306 |
artikel |
25 |
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report
|
Sahebi, Firoozeh |
|
|
25 |
2 |
p. 335-342 |
artikel |
26 |
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis
|
Salhotra, Amandeep |
|
|
25 |
2 |
p. 287-292 |
artikel |
27 |
Over-expression of PD-1 Does Not Predict Leukemic Relapse after Allogeneic Stem Cell Transplantation
|
Jain, Prachi |
|
|
25 |
2 |
p. 216-222 |
artikel |
28 |
Patient Perspectives Regarding Allogeneic Bone Marrow Transplantation in Myelofibrosis
|
Palmer, Jeanne |
|
|
25 |
2 |
p. 398-402 |
artikel |
29 |
Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival
|
Alousi, Amin |
|
|
25 |
2 |
p. 270-278 |
artikel |
30 |
Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia
|
Andolina, Jeffrey R. |
|
|
25 |
2 |
p. 321-327 |
artikel |
31 |
Recombinant Pregnancy-Specific Glycoprotein 1 Has a Protective Role in a Murine Model of Acute Graft-versus-Host Disease
|
Jones, Karlie |
|
|
25 |
2 |
p. 193-203 |
artikel |
32 |
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease
|
Modi, Badri |
|
|
25 |
2 |
p. 265-269 |
artikel |
33 |
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study
|
Gupta, Vikas |
|
|
25 |
2 |
p. 256-264 |
artikel |
34 |
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association–Hematopoietic Stem Cell Transplantation Group
|
Faraci, Maura |
|
|
25 |
2 |
p. 313-320 |
artikel |
35 |
Table of Contents
|
|
|
|
25 |
2 |
p. A11-A16 |
artikel |
36 |
The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease
|
Gandelman, Jocelyn S. |
|
|
25 |
2 |
p. 279-286 |
artikel |
37 |
Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia
|
Ochi, Tetsuro |
|
|
25 |
2 |
p. e55-e59 |
artikel |